Bilibili Inc.
15.91USD
-0.2900 (-1.79%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.8▼ | $1.82 | 3 | 5 |
| Next quarter | $2.12▼ | $2.22 | 3 | 4 |
| Current year | $6.82▼ | $7.01 | 6 | 14 |
| Next year | $8.64▼ | $9.15 | 6 | 14 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.53 | $1.58 | +0.05 (+3.0%) |
| 2026-03-31 | $1.16 | $1.31 | +0.15 (+13.4%) |
| 2025-12-31 | $1.84 | $1.94 | +0.10 (+5.5%) |
| 2025-09-30 | $1.5 | $1.75 | +0.25 (+17.0%) |
109 ratings from 22 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $25 $31 | Apr 13, 2026 |
| Citigroup | Upgraded from Neutral | Buy | $27 | Mar 27, 2026 |
| JP Morgan | Upgraded from Neutral | Overweight | $27 $35 | Mar 17, 2026 |
| B of A Securities | Maintained | Buy | $32 $31 | Nov 28, 2025 |
| JP Morgan | Maintained | Neutral | $24 $27 | Nov 18, 2025 |
| Citigroup | Maintained | Neutral | $25 $27 | Nov 14, 2025 |
| Benchmark | Maintained | Buy | $28 $29 | Nov 14, 2025 |
| Bernstein | Maintained | Outperform | $28 $32 | Oct 23, 2025 |
| Macquarie | Initiated | Outperform | $36.03 | Oct 14, 2025 |
| Barclays | Maintained | Overweight | $25 $28 | Aug 22, 2025 |
| Benchmark | Maintained | Buy | $30 $28 | Aug 22, 2025 |
| JP Morgan | Downgraded from Overweight | Neutral | $21 $24 | Jul 28, 2025 |
| B of A Securities | Maintained | Buy | $25 $27 | Jul 17, 2025 |
| Bernstein | Initiated | Outperform | $28 | Jul 8, 2025 |
| HSBC | Upgraded from Hold | Buy | $21.5 $22.5 | May 21, 2025 |
| Benchmark | Maintained | Buy | $24 $30 | Feb 21, 2025 |
| Barclays | Maintained | Overweight | $24 $25 | Feb 21, 2025 |
| Barclays | Maintained | Overweight | $19 $24 | Nov 18, 2024 |
| Benchmark | Maintained | Buy | $16 $24 | Nov 15, 2024 |
| Mizuho | Maintained | Outperform | $17 $21 | Nov 12, 2024 |
| B of A Securities | Maintained | Buy | $19 $22.5 | Oct 25, 2024 |
| B of A Securities | Maintained | Buy | $18 $19 | Sep 3, 2024 |
| Bernstein | Maintained | Market Perform | $12 $13 | Aug 23, 2024 |
| Barclays | Upgraded from Equal-Weight | Overweight | $14 $19 | Aug 23, 2024 |
| Nomura | Upgraded from Neutral | Buy | $18 | Aug 22, 2024 |
No analyst notes on BILI yet.
Analyst Ratings
29 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 23 | 1 | 0 | 0 | Buy1.86 |
| 1 mo ago | 5 | 24 | 1 | 0 | 0 | Buy1.87 |
| 2 mo ago | 6 | 23 | 1 | 0 | 0 | Buy1.83 |
| 3 mo ago | 5 | 24 | 1 | 0 | 0 | Buy1.87 |